Vinay Prasad Reinstated at FDA Amid Renewed Controversy and Loomer Attacks
Vinay Prasad Reinstated at FDA Amid Renewed Controversy and Loomer Attacks Just over a week after his contentious departure, Dr. Vinay Prasad has been reinstated as the head of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research. The decision, confirmed by Department Health and Human Services spokesperson Andrew Nixon, sees Prasad returning to his critical role overseeing vaccine, gene therapy, and blood product regulation. Prasad, an oncologist known for his past criticisms of Covid-19 vaccine…